JPMorgan Chase & Co’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-129
| Closed | -$1K | – | 6237 |
|
|
2022
Q1 | $1K | Buy |
+129
| New | +$1K | ﹤0.01% | 5689 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | – | – | 5846 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5562 |
|
|
2020
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5300 |
|
|
2019
Q4 | – | Sell |
-1,773
| Closed | -$886K | – | 4958 |
|
|
2019
Q3 | $886K | Buy |
1,773
+478
| +37% | +$239K | ﹤0.01% | 3118 |
|
|
2019
Q2 | $719K | Buy |
1,295
+623
| +93% | +$346K | ﹤0.01% | 3202 |
|
|
2019
Q1 | $410K | Buy |
672
+84
| +14% | +$51.3K | ﹤0.01% | 3460 |
|
|
2018
Q4 | $215K | Sell |
588
-51
| -8% | -$18.6K | ﹤0.01% | 3784 |
|
|
2018
Q3 | $431K | Buy |
+639
| New | +$431K | ﹤0.01% | 3551 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$126K | – | 4906 |
|
|
2018
Q1 | $126K | Buy |
100
+62
| +163% | +$78.1K | ﹤0.01% | 3862 |
|
|
2017
Q4 | $57K | Buy |
+38
| New | +$57K | ﹤0.01% | 4092 |
|